Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1414
https://www.valueinhealthjournal.com/article/S1098-3015(13)03319-6/fulltext
Title :
Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03319-6&doi=10.1016/j.jval.2013.08.1414
First page :
A549
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1258